Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaiqihuang Granules in CKD3 Primary Glomerulonephritis
NCT04263922Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jun 2020
- Primary completion
- Oct 2025
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Huaiqihuang in primary glomerulonephritis, sponsored by The First Affiliated Hospital of Dalian Medical University. Started Jun 2020; status: recruiting.
02
Drugs
Huaiqihuang
03
Conditions
primary glomerulonephritis
Beyond the preview
Go deeper on NCT04263922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263922.